Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$0.63 - $1.59 $78,068 - $197,029
-123,918 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$1.27 - $2.42 $647 - $1,234
-510 Reduced 0.41%
123,918 $157,000
Q3 2021

Nov 10, 2021

BUY
$2.15 - $3.82 $1,019 - $1,810
474 Added 0.38%
124,428 $271,000
Q2 2021

Aug 12, 2021

BUY
$2.89 - $4.45 $33,000 - $50,814
11,419 Added 10.15%
123,954 $465,000
Q1 2021

May 12, 2021

SELL
$2.9 - $4.09 $1,461 - $2,061
-504 Reduced 0.45%
112,535 $367,000
Q4 2020

Feb 12, 2021

SELL
$3.38 - $5.14 $158 - $241
-47 Reduced 0.04%
113,039 $385,000
Q3 2020

Nov 12, 2020

BUY
$2.99 - $4.9 $165,344 - $270,965
55,299 Added 95.69%
113,086 $461,000
Q2 2020

Aug 11, 2020

BUY
$2.11 - $3.38 $1,998 - $3,200
947 Added 1.67%
57,787 $195,000
Q1 2020

May 14, 2020

BUY
$1.83 - $3.45 $33,928 - $63,963
18,540 Added 48.41%
56,840 $132,000
Q4 2019

Feb 11, 2020

BUY
$3.5 - $10.35 $73 - $217
21 Added 0.05%
38,300 $139,000
Q3 2019

Nov 14, 2019

BUY
$7.03 - $9.7 $13,005 - $17,945
1,850 Added 5.08%
38,279 $318,000
Q2 2019

Aug 13, 2019

BUY
$7.36 - $11.26 $1,626 - $2,488
221 Added 0.61%
36,429 $314,000
Q1 2019

May 07, 2019

BUY
$9.08 - $11.84 $12,539 - $16,351
1,381 Added 3.97%
36,208 $387,000
Q4 2018

Feb 11, 2019

BUY
$6.39 - $16.99 $71,746 - $190,763
11,228 Added 47.58%
34,827 $305,000
Q3 2018

Nov 08, 2018

BUY
$16.52 - $24.82 $62,594 - $94,042
3,789 Added 19.13%
23,599 $396,000
Q2 2018

Aug 03, 2018

BUY
$14.31 - $21.75 $283,481 - $430,867
19,810 New
19,810 $415,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.